No Material Deviation in Financial Statements. All consolidated financial statements for Borrower and any of its Subsidiaries delivered to Collateral Agent fairly present, in all material respects Borrower’s consolidated financial condition and Borrower’s consolidated results of operations. There has not been any material deterioration in Borrower’s consolidated financial condition since the date of the most recent financial statements submitted to Collateral Agent.
Appears in 1 contract
Sources: Loan and Security Agreement (Complete Genomics Inc)
No Material Deviation in Financial Statements. All consolidated financial statements for Borrower and any of its Subsidiaries delivered to Collateral Agent fairly present, in conformity with GAAP (except for interim financial statements subject to normal year-end adjustments and footnotes), in all material respects Borrower’s consolidated financial condition and Borrower’s consolidated results of operations. There has not been any material deterioration in Borrower’s consolidated financial condition since the date of the most recent financial statements submitted to Collateral Agent.
Appears in 1 contract
Sources: Loan and Security Agreement (Apex Bioventures Acquisition Corp)
No Material Deviation in Financial Statements. All consolidated financial statements for Borrower and any of its Subsidiaries delivered to Collateral Agent fairly present, in all material respects Borrower’s consolidated financial condition and Borrower’s consolidated results of operations, in each case as of the respective dates hereof. There Except with respect to spending of cash in the ordinary course of business, provided that Borrower is not in violation of any other provision hereof, there has not been any material deterioration in Borrower’s consolidated financial condition since the date of the most recent financial statements submitted to Collateral Agent.
Appears in 1 contract
Sources: Loan and Security Agreement (Somaxon Pharmaceuticals, Inc.)